Potassium Chloride Tablet, Film Coated, Extended Release
Product Images NDC 65862-987

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Potassium Chloride (NDC 65862-987). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (8 mEq (600 mg) (100 Tablets Bottle))

Package Label-principal Display Panel (8 mEq (600 mg) (100 Tablets Bottle))
This is a description of Potassium Chloride Extended-Release Tablets, USP with NDC 65862-986-01. This medication is manufactured by Aurobindo Pharma USA, Inc. and contains 100 tablets per bottle. Each film-coated extended-release tablet contains 600mg of Potassium Chloride USP. It is recommended to follow the full prescribing information for dosage adjustments based on individual patient needs. The medication should be stored at a controlled room temperature of 20° to 25° C (68° to 77° F) to protect it from light and moisture. The expended matrix is not absorbed and may be excreted intact in stool. It is essential to keep the medication out of the reach of children. The FDA approved acceptance criteria for assay differs from the USP test.*
FDA Label Image

Package Label-principal Display Panel (8 mEq (600 mg) Blister Carton (20 x 4 Unit-Dose Tablets) Label)

Package Label-principal Display Panel (8 mEq (600 mg) Blister Carton (20 x 4 Unit-Dose Tablets) Label)
This is a prescription medication with the brand name Aurobindo. It comes in the form of extended-release tablets that contain 8mEq (600mg) of Potassium Chloride. The manufacturer is Aurobindo Pharma, and the product is available in a pack of 20 x 4 unit-dose tablets. The NDC number is 65862-986-80. The text also contains some irrelevant characters and symbols.*
FDA Label Image

Package Label-principal Display Panel (10 mEq (750 mg) (100 Tablets Bottle)

Package Label-principal Display Panel (10 mEq (750 mg) (100 Tablets Bottle)
This is a description of a medication with the NDC code 65862-987-01. The medication is Potassium Chloride with an extended-release formula in 10 mEq or 750 mg tablets. It is manufactured by Aurobindo Pharma USA, Inc. and made in India. The medication needs to be stored in a tight container, away from light and moisture, and between 20° to 25° C. The user must refer to the package insert for full prescribing information and to adjust dosage according to individual needs. It is important to be aware that the expended matrix is not absorbed and may be excreted in stool. The FDA-approved criteria for assay differs from the USP test. The medication should be kept away from children.*
FDA Label Image

Package Label-principal Display Panel (10 mEq (750 mg) Blister Carton (20 x 4 Unit-Dose Tablets) Label)

Package Label-principal Display Panel (10 mEq (750 mg) Blister Carton (20 x 4 Unit-Dose Tablets) Label)
This is a prescription medication that contains potassium chloride in the form of extended-release tablets. The tablets are available in a 50-count bottle and each tablet provides 10 milliequivalents of potassium chloride. The manufacturer is Aurobindo Pharma USA and the product is distributed in a 20 x 4 unit-dose. The medication is intended for outpatient use only and should be taken according to the prescribing physician's instructions. The listed address for the manufacturer is 279 Poncson Hghsiow Fiad, EtWmasor, and the product is labeled with an NDC number of 65862-987-80.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.